MİRİLİ, C. Et Al. 2020. Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer. JOURNAL OF BUON , vol.25, no.1 , 159-167.

MİRİLİ, C., PAYDAŞ, S., BAĞIR KILIÇ, E., SEYDAOĞLU, G., OĞUL, A., GÖKÇAY, S., ... BÜYÜKŞİMŞEK, M.(2020). Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer. JOURNAL OF BUON , vol.25, no.1, 159-167.

MİRİLİ, CEM Et Al. "Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer," JOURNAL OF BUON , vol.25, no.1, 159-167, 2020

MİRİLİ, CEM Et Al. "Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer." JOURNAL OF BUON , vol.25, no.1, pp.159-167, 2020

MİRİLİ, C. Et Al. (2020) . "Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer." JOURNAL OF BUON , vol.25, no.1, pp.159-167.

@article{article, author={CEM MİRİLİ Et Al. }, title={Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer}, journal={JOURNAL OF BUON}, year=2020, pages={159-167} }